181 related articles for article (PubMed ID: 36301489)
21. CD155, an onco-immunologic molecule in human tumors.
Gao J; Zheng Q; Xin N; Wang W; Zhao C
Cancer Sci; 2017 Oct; 108(10):1934-1938. PubMed ID: 28730595
[TBL] [Abstract][Full Text] [Related]
22. PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma.
Lee BH; Kim JH; Kang KW; Lee SR; Park Y; Sung HJ; Kim BS
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625835
[TBL] [Abstract][Full Text] [Related]
23. CD155: A Key Receptor Playing Diversified Roles.
Nandi SS; Gohil T; Sawant SA; Lambe UP; Ghosh S; Jana S
Curr Mol Med; 2022; 22(7):594-607. PubMed ID: 34514998
[TBL] [Abstract][Full Text] [Related]
24. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
25. Targeting PVR (CD155) and its receptors in anti-tumor therapy.
Kučan Brlić P; Lenac Roviš T; Cinamon G; Tsukerman P; Mandelboim O; Jonjić S
Cell Mol Immunol; 2019 Jan; 16(1):40-52. PubMed ID: 30275538
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of CD155 mRNA expression in soft tissue sarcomas.
Atsumi S; Matsumine A; Toyoda H; Niimi R; Iino T; Sudo A
Oncol Lett; 2013 Jun; 5(6):1771-1776. PubMed ID: 23833639
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155).
Fuchs A; Cella M; Giurisato E; Shaw AS; Colonna M
J Immunol; 2004 Apr; 172(7):3994-8. PubMed ID: 15034010
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
[TBL] [Abstract][Full Text] [Related]
29. Differential patterns of metastatic dissemination across medulloblastoma subgroups.
Zapotocky M; Mata-Mbemba D; Sumerauer D; Liby P; Lassaletta A; Zamecnik J; Krskova L; Kyncl M; Stary J; Laughlin S; Arnoldo A; Hawkins C; Tabori U; Taylor MD; Bouffet E; Raybaud C; Ramaswamy V
J Neurosurg Pediatr; 2018 Feb; 21(2):145-152. PubMed ID: 29219788
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.
Deogharkar A; Singh SV; Bharambe HS; Paul R; Moiyadi A; Goel A; Shetty P; Sridhar E; Gupta T; Jalali R; Goel N; Gadewal N; Muthukumar S; Shirsat NV
Hum Mol Genet; 2021 Aug; 30(18):1721-1733. PubMed ID: 33949667
[TBL] [Abstract][Full Text] [Related]
31. CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Jin AL; Zhang CY; Zheng WJ; Xian JR; Yang WJ; Liu T; Chen W; Li T; Wang BL; Pan BS; Li Q; Cheng JW; Wang PX; Hu B; Zhou J; Fan J; Yang XR; Guo W
Clin Transl Med; 2022 Apr; 12(4):e794. PubMed ID: 35384345
[TBL] [Abstract][Full Text] [Related]
32. CD155 in tumor progression and targeted therapy.
Zhan M; Zhang Z; Zhao X; Zhang Y; Liu T; Lu L; Li XY
Cancer Lett; 2022 Oct; 545():215830. PubMed ID: 35870689
[TBL] [Abstract][Full Text] [Related]
33. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
34. Poliovirus Receptor: More than a simple viral receptor.
Bowers JR; Readler JM; Sharma P; Excoffon KJDA
Virus Res; 2017 Oct; 242():1-6. PubMed ID: 28870470
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.
Remke M; Hering E; Gerber NU; Kool M; Sturm D; Rickert CH; Gerß J; Schulz S; Hielscher T; Hasselblatt M; Jeibmann A; Hans V; Ramaswamy V; Taylor MD; Pietsch T; Rutkowski S; Korshunov A; Monoranu CM; Frühwald MC
Childs Nerv Syst; 2013 Aug; 29(8):1253-62. PubMed ID: 23677175
[TBL] [Abstract][Full Text] [Related]
36. The risk of unintentional propagation of poliovirus can be minimized by using human cell lines lacking the functional CD155 gene.
Koike S
Microbiol Immunol; 2020 Dec; 64(12):835-839. PubMed ID: 32902876
[TBL] [Abstract][Full Text] [Related]
37. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
[TBL] [Abstract][Full Text] [Related]
38. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
[TBL] [Abstract][Full Text] [Related]
39. Poliovirus nonpermissive CD155 knockout cells derived from RD cell line for handling poliovirus potentially infectious materials in virology laboratories.
Nandi SS; Sawant S; Gohil T; Lambe U; Sangal L; Patel D; Krishnasamy K; Ghoshal U; Harvey P; Deshpande J
J Med Virol; 2022 Oct; 94(10):4901-4909. PubMed ID: 35642597
[TBL] [Abstract][Full Text] [Related]
40. MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
Panwalkar P; Moiyadi A; Goel A; Shetty P; Goel N; Sridhar E; Shirsat N
J Mol Neurosci; 2015 Jul; 56(3):673-80. PubMed ID: 25859932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
